Novel Therapy for Atherosclerosis Using Recombinant Immunotoxin Against Folate Receptor β-Expressing Macrophages.

22 Although α-SMA–expressing cells tended to decrease in the immunotoxin groups at 21 and 41 weeks of age, these differences did not reach statistical significance, and there was no significant difference in CD3-expressing cells ( Table 2 ).

also in 111,027 other papers